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Introduction 
 
This report was commissioned by the Marengo Memorial Hospital to evaluate the market 
potential for a new kidney dialysis facility. Marengo Memorial Hospital is a rural hospital located 
in Marengo, a town of 2,535 people in north central Iowa County, Iowa (see the star in Map 1).  
In 2001, the hospital reported a capacity of 25 acute-care beds, 228 admissions, 8,485 inpatient 
admission days, and 8,750 outpatient visits. 
 
Marengo Memorial Hospital intends to add space in order to expand its wellness, health 
maintenance, and community programs.  One of the options for use of this added space is a five-
station hemodialysis facility.  Our primary goal is to determine whether there is enough current 
and anticipated demand for in-center hemodialysis services within the immediate area and 
surrounding region to support such a facility.  Our secondary aim is to determine the utilization 
levels at which a five-station hemodialysis facility’s operations can be self-financed. 
 
For the purposes of this report, it is assumed that suitable facility space will be included in 
hospital expansion, regardless of whether the space is utilized for dialysis operations.  This report 
focuses on the potential market for and operational costs and revenues associated with the 





Wherever possible, in this study, data has been identified for the City of Marengo, Iowa County, 
the immediate area, the surrounding region, and the State of Iowa.  The immediate area includes: 
 
Iowa County  Benton County  Johnson County 
Keokuk County  Linn County  Poweshiek County 
Tama County  Washington County   
 
The immediate area includes Iowa County and all of its contiguous counties.  It encompasses 
virtually all of the area within 30 miles of Marengo.  At the northern and southeastern corners it 
extends about 50 miles from Marengo. 
 
The surrounding region includes the immediate area plus: 
 
Appanoose County  Bremer County  Buchanan County 
Butler County  Cedar County  Clayton County 
Clinton County  Davis County  Delaware County 
Des Moines County  Dubuque County  Fayette County 
Grundy County  Hardin County  Henry County 
Jackson County  Jasper County  Jefferson County 
Jones County  Lee County  Louisa County 
Lucas County  Mahaska County  Marion County 
Marshall County  Monroe County  Muscatine County 
Polk County  Scott County  Story County 
Van Buren County  Wapello County  Warren County 
 
The surrounding region includes nearly all of the area that is both within the State of Iowa and 








































   - 3 -   
Regional Dialysis Capacity 
 
Map 1 shows the locations and relative capacities (number of dialysis chairs) of dialysis centers 
in the immediate area and the larger region surrounding Marengo.  In larger communities 
containing multiple dialysis centers, only one spot is used to show the sum of chairs available 
from all of the centers in the community.  Red spots indicate publicly owned dialysis facilities.  
Pink spots represent privately owned facilities.  Split spots represent the proportion of public to 
private capacity (chairs) in the community.  Spot size represents capacity size relative to all of the 
dialysis facilities in the region.  Table 1 provides the data supporting Map 1, including 
community names and the number of publicly owned and privately owned dialysis chairs 
available in these communities. 
 
Table 1 shows that there are 74 dialysis chairs, all publicly owned, in Marengo’s immediate area.  
Of these chairs, all but 28 (22 in Cedar Rapids and 6 in Vinton) are owned by or affiliated with 
the University of Iowa Hospitals and Clinics.  Directly to the north and east, 56 of the area’s 
chairs sit within 25-to-30 miles of Marengo.  Fifty of these 56 are located within the Iowa City 
and Cedar Rapids urban areas.  There are 427 dialysis chairs within the region.  Of these, 353 are 
outside of the immediate area. 
 
 
Regional Dialysis Patients 
 
Table 2 shows the number of dialysis patients resident in regional counties in June 2001 and June 
2003 reported by the End-Stage Renal Disease (ESRD) Network.  These reports included 4 
dialysis patients resident in Iowa County, 200 total patients in the immediate area, and 1288 total 
patients within the region in 2003.  Looking back to the dialysis capacity data from Table 1, we 
estimate that the 74 dialysis chairs in the immediate area support an average of 2.7 dialysis 
patients, each.  The 427 total dialysis chairs in the region support an estimated of 3.0 patients, 
each. 
 
Assuming no increase in the number of dialysis patients in the immediate area, the addition of 
five dialysis chairs in Marengo would dilute the average patient per chair ratio in the immediate 
area to 2.5.  The addition of chairs would not significantly change the average patient per chair 
ratio for the entire region. 
 
Map 2 adds the number of reported dialysis patients by zip code area (June 2003) to the dialysis 
facilities included in Map 1.  Areas in Map 2 where the blue or yellow background colors of the 
immediate area and surrounding region can be seen indicate zip codes for which no dialysis 
patients were reported. 
 
 
Incidence and Prevalence of Dialysis and Kidney Disease 
 
“Incidence” and “Prevalence” are two important terms when looking at the demand for treatment 
of ESRD or any disease.  “Incidence” refers to the number of new cases of the disease that are 
reported in a given time period (usually a year).  “Incidence rates” refer to the rate at which 
incidence strikes the population.  In the case of ESRD statistics, incidence rates refer to the 
number of incident cases per million people. 
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“Prevalence” refers to the number of living patients reporting cases of the disease at a particular 
time.  For ESRD statistics, prevalence refers to counts of living patients on December 31 of any 
year.  As with incidence, ESRD prevalence rates are reported in terms of patients per million 
people in the population. 
 
 
Table 1.  Regional Dialysis Chairs 
City  For Profit  Nonprofit  Total 
       
Cedar Rapids    22  22 
Grinnell    12  12 
Iowa City    16  16 
North Liberty    12  12 
Vinton    6  6 
Washington    6  6 
Immediate Area    74  74 
       
Ames    17  17 
Clinton    13  13 
Davenport  19  24  43 
Des Moines  41  20  61 
Dubuque  32   32 
Guttenberg  5   5 
Independence    12  12 
Iowa Falls    8  8 
Keokuk  10   10 
Manchester  9   9 
Maquoketa    8  8 
Marshalltown    12  12 
Mount Pleasant    12  12 
Muscatine    12  12 
Newton  8   8 
Ottumwa    12  12 
Pella    9  9 
Waterloo  24  25  49 
Waverly    9  9 
West Burlington  12   12 
Regional Total  160  267  427 
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Table 2.  Regional Dialysis Patients as of June 30, 2001 
  And June 30, 2003 
  2001 2003    2001 2003
             
State of Iowa   1946 1911  Regional Total  1322 1288
           Appanoose  11 14
Iowa County  4 4     Black Hawk  124 120
           Bremer  19 20
Immediate Area  219 200     Buchanan  20 17
   Benton  14 17     Butler  16 17
   Johnson  49 41     Cedar  10 10
   Keokuk  8 7     Clayton  15 17
   Linn  114 107     Clinton  38 46
   Poweshiek  11 7     Davis  6 6
   Tama  10 10     Delaware  12 11
   Washington  9 7     Des Moines  39 38
           Dubuque  86 97
           Fayette  14 8
           Grundy  8 10
           Hardin  11 15
           Henry  15 18
           Jackson  19 15
           Jasper  22 18
           Jefferson  7 7
           Jones  13 19
           Lee  43 29
           Louisa  6 7
           Lucas  5 7
           Mahaska  9 10
           Marion  21 20
           Marshall  27 31
           Monroe  7 5
           Muscatine  23 20
           Polk  247 225
           Scott  127 122
           Story  19 27
           Van Buren  4 4
           Wapello  35 36
           Warren  25 22
ESRD Network 12.  www.esrdnetworks.org, January 2004. 
 
The relationship between incidence and prevalence depends upon the rate at which the disease is 
successfully cured and patient life expectancy.  Unfortunately, in the case of ESRD, the rate of 
successful cure is too low to be a factor in the analysis, so incidence and prevalence are linked by 
life expectancy.  In a case where the life expectancy of new patients of a disease is less than one 
year, incidence would exceed prevalence.  In the case of ESRD, patient life expectancy is greater 
than one year, so prevalence, the measure of living patients, is greater than incidence, the measure 
of new patients.  Life expectancy (or, more specifically, the probability of surviving a given 
number of years after diagnosis) is steadily increasing for ESRD patients.  This means that 
prevalence is not only greater than incidence, but that prevalence, the number of living patients, is 
growing faster than incidence, the number of newly diagnosed patients.  This is true of both Iowa 
and the United States, and can be seen in Graph 1 and Graph 2. 
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Between 97 percent and 98 percent of all new (incident) cases of ESRD, nationwide, are treated 
through some form of dialysis.  This has been steadily true since 1978, with the exception of a 
brief dip between 1987 and 1993, which was accompanied by an increased kidney transplantation 
rate for new ESRD patients.  Of incident cases on dialysis, the percentage utilizing in-center 
hemodialysis has grown from 80.2 percent in 1985 to 91.6 percent in 2001. 
 
    
Graph 1.  ESRD Incidence Rates Per Million Population 
Data derived from United States Renal Data System, www.usrds.org 
 
The importance of this is apparent from the trend shown in Graph 1.  Graph 1 shows that 
incidence rates for ESRD are steadily rising for the United States.  The graph also shows that 
Iowa ESRD Incidence rates are growing, although not so steadily (the variation seen in the Iowa 
trendline is at least partially due to the smaller population for which the trend is measured).  
Given that a growing proportion of new ESRD patients are treated with in-center hemodialysis, a 
growing ESRD incidence rate results in a magnified growth in incident in-center hemodialysis 
demand that results from newly diagnosed ESRD cases. 
 
The trend in dialysis use is different when the focus is on prevalent ESRD cases.  From 1978 to 
2001, the percentage of prevalent ESRD patients utilizing dialysis dropped from 86.5 percent to 
72 percent, nationwide.  This primarily reflects the increased availability of kidney 
transplantation as a successful treatment option.  The proportion of dialysis patients among the 
prevalent population that utilizes in-center hemodialysis has grown, however, from 75.6 percent 
in 1985 to 90.1 percent in 2001.  The result is that, in 1985, 58 percent of prevalent ESRD 
patients utilized in-center hemodialysis.  This share has grown to 64.9 percent in 2001.  The 
increasing prevalent patient share of in-center hemodialysis among all dialysis users continues to 
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Just as the importance of increasing utilization of in-center hemodialysis by incident ESRD 
patients magnifies the in-center hemodialysis demand pressure exerted by increasing ESRD 
incidence rates, so does the increasing share of prevalent ESRD patients utilizing in-center 
hemodialysis.  Graph 2 shows the increasing ESRD prevalence rates for the United States and 
Iowa.  While the rate of prevalence in Iowa remains below that of the United States, both are 
consistently growing.  This points to an expectation of continued increases in demand for in-
center hemodialysis in the foreseeable future. 
 
 
Graph 2.  ESRD Prevalence Rates Per Million Population 
Data derived from United States Renal Data System, www.usrds.org 
 
Regional Population Trends and Projection 
 
Marengo is a town of 2,535 people in north central Iowa County, Iowa.  From 1990 to 2000, 
Marengo’s population grew by 265 people, or over 11.5 percent.  Iowa County, of which 
Marengo is the county seat, had a population of 15,671 in 2000, according to the U.S. Census.  
This reflected an increase of 1,041, or over seven percent, from 1990. 
 
This section looks at historical and projected population growth for Iowa County, the immediate 
area, and the surrounding region.  In addition to total population, the section looks at historical 
white and nonwhite populations and both historical and projected age distributions.  An 
understanding of these subpopulations is important to understanding the demand for in-center 
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Table 3 shows total population for Marengo, the immediate area, and the region reported by the 
1990 and 2000 Census, as well as projections for the county-based areas for 2010.  The 
projections are based upon an economic model that takes into account recent trends in population, 
employment, economic activity, and relative proximity to urban areas.  The model and 
projections are part of an ongoing regional research effort at Iowa State University.  Data for 
Iowa County is shown in red on the table.  Yellow highlighted entries in the “Percent Change” 
columns show growth for the corresponding areas and ten-year periods.  Unhighlighted columns 
represent declining area-period combinations.  With the exception of Iowa County data, which is 
red, projected data or calculations that depend upon projected data are shown in blue. 
 
Table 3 shows growth in all of the listed areas except Keokuk and Poweshiek counties (part of the 
immediate area) between 1990 and 2000.  The primary growth areas within Marengo’s immediate 
area during this period were Benton, Johnson, and Linn counties.  These three counties are the 
only counties in the immediate area that are projected to grow between 2000 and 2010.  Iowa 
County is projected to lose 567 people over the current decade. 
 
It is expected, however, that much of the projected growth in Benton, Johnson, and Linn counties 
will take place on the western edge of the Iowa City-Cedar Rapids corridor.  This would result in 
substantial population growth in an area 15-to-25 miles east of Marengo, immediately between 
Marengo and the closest existing dialysis facilities. 
 
 
Table 3. Regional Population Growth: Historical and Projected 
            Percent Change 
      1990 2000 2010 90-00 00-10
               
  Marengo  2,270 2,535  11.67 
               
  Immediate Area  369,633 412,674 444,321 11.64 7.67
    Iowa County  14,630 15,671 15,104 7.12 -3.62
    Benton  22,429 25,308 26,523 12.84 4.80
    Johnson  96,119 111,006 126,778 15.49 14.21
    Keokuk  11,624 11,400 10,856 -1.93 -4.77
    Linn  168,767 191,701 208,615 13.59 8.82
    Poweshiek  19,033 18,815 18,335 -1.15 -2.55
    Tama  17,419 18,103 17,659 3.93 -2.45
    Washington  19,612 20,670 20,451 5.39 -1.06
               
  Regional Total  1,801,028 1,927,893 2,006,467 7.04 4.08
  State of Iowa  2,776,755 2,926,324 2,994,094 5.39 2.32
U.S. Census Data 
Jintanakul, Kanlaya, Dan Otto, and Mark Imerman. Work in progress.  
Iowa State University Department of Economics. 2004. 
 
Table 4 shows total, white, and nonwhite populations for Iowa County, the entire immediate area, 
and the entire region for 1990 and 2000.  No projections based on race are available.  The table 
also shows white and nonwhite populations as a percent of total for each year and the percentage 
growth in each population category over the decade.  While the table shows that populations in all 
categories rose over the decade, nonwhite populations clearly grew at a faster rate than white   - 10 -   
populations, throughout.  As a result, nonwhite populations held a larger population share in 2000 
than they did in 1990.  All indications are that this trend will continue, and may accelerate. 
 
 
Table 4. Regional White and Nonwhite Populations 
      Population  Percent of Total  % Change 
      1990  2000  1990  2000  90-00 
             
  Iowa County           
    Total  14,630 15,671    7.12
    White  14,566 15,467 99.56 98.70 6.19
    Nonwhite  64 204 0.44 1.30 218.75
               
  Immediate Area         
    Total  369,633 412,674    11.64
    White  355,834 386,441 96.27 93.64 8.60
    Nonwhite  13,799 26,233 3.73 6.36 90.11
               
  Regional Total           
    Total  1,801,028 1,927,893    7.04
    White  1,722,534 1,789,452 95.64 92.82 3.88
    Nonwhite  78,494 138,441 4.36 7.18 76.37
               
  State of Iowa           
    Total  2,776,755 2,926,324    5.39
    White  2,683,090 2,748,640 96.63 93.93 2.44
    Nonwhite  93,665 177,684 3.37 6.07 89.70
U.S. Census 
 
This is important because of the substantial differences that exist in incidence and prevalence 
rates between racial categories.  Table 5 shows that both the incident and prevalent rates for 
ESRD in the U.S. are much lower for the white population than for the total.  The table also 
shows that white incident rates grew faster between 1980 and 2001 than all other groups except 
Asians.  Long-term, this opens the possibility of more equivalent prevalence rates.  At the 
moment, however, a growing nonwhite population can be expected to accelerate the growth in 
area ESRD prevalence and the demand for in-center hemodialysis.  
 
Table 6 shows historical population by age for the area and region for 1990 and 2000 and 
projected population by age for 2010.  Table 7 shows the actual change in populations by age 
from 1990 through 2000 and the projected changes in populations by age from 2000 to 2010.  The 
projected population changes in Table 7 show an expectation that populations are going to 
become older, both in counties and with overall population growth and in counties where overall 
population declines.  In all cases, the population aged 50-and-over is expected to increase 
between 2000 and 2010.  In all but two of the immediate area counties (Keokuk and Poweshiek), 
the population aged 40-and-over is expected to increase (Keokuk and Poweshiek counties are also 
the only two immediate-area counties to have lost population between 1990 and 2000). 
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Table 5. U.S. ESRD Incidence Rates and Prevalence Rates 
  By Race (per million population)  
              %Chg
  1980 1985 1990 1995 2000 2001 80-01
Prevalence 
Tot. Pop.  242 445 698 1,044 1,360 1,403 480%
White  180 339 529 772 1,013 1,050 483%
Black  706 1,181 1,824 2,762 3,499 3,579 407%
Nat. Am.  328 670 1,150 1,992 2,565 2,579 686%
Asian  126 415 659 1,053 1,341 1,380 995%
 
Incidence 
Tot. Pop.  74 122 191 267 332 336 354%
White  54 96 150 202 266 269 398%
Black  215 299 470 680 761 771 259%
Nat. Am.  122 179 332 547 524 494 305%
Asian  41 151 160 261 286 288 602%
Data derived from United States Renal Data System, www.usrds.org 
 
Increasing populations in the upper age groups are important because of the substantial 
differences that exist in both incidence and prevalence rates among the age groups.  Table 8 
shows both incidence and prevalence rates by age for the U.S. at five-year intervals from 1980.  
Both incidence and prevalence rates increase substantially with age until age 75 for all of the 
years shown.  Equally as important for forecasting in-center hemodialysis demand, the rates of 
growth for both incidence and prevalence from 1980 to 2001 increase as age increases.  Expected 
population change in Marengo’s immediate area lead to an expectation of increased ESRD 
patients and increased demand for hemodialysis services. 
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Table 6. Population by Age for 1990, 2000, and 2010 (Projected) 
  1990  Tot. Pop.  0 to 9  10 to 16  17 to 24  25 to 29  30 to 39  40 to 49  50 to 59  60 to 69  70 & over 
Immediate Area  369,633 51,256 33,412 55,435 32,100 60,678 44,113 31,436 28,140 33,063
  Iowa County  14,630 2,152 1,398 1,176 1,055 2,263 1,641 1,444 1,490 2,011
  Benton  22,429 3,463 2,445 1,974 1,626 3,456 2,619 2,082 2,070 2,694
  Johnson  96,119 11,964 6,506 24,744 10,610 16,683 10,245 5,754 4,624 4,989
  Keokuk  11,624 1,718 1,154 914 782 1,660 1,222 1,153 1,247 1,774
  Linn  168,767 24,054 16,135 20,773 14,337 28,410 21,988 15,712 13,284 14,074
  Poweshiek  19,033 2,538 1,859 2,652 1,197 2,780 2,173 1,762 1,764 2,308
  Tama  17,419 2,433 1,867 1,513 1,089 2,441 1,972 1,785 1,807 2,512
  Washington  19,612 2,934 2,048 1,689 1,404 2,985 2,253 1,744 1,854 2,701
Regional Total  1,801,028 258,955 176,521 229,378 142,083 288,539 219,694 159,106 150,805 175,947
State of Iowa  2,776,755 402,541 279,013 321,039 206,616 434,123 329,253 250,711 249,807 303,652
                       
  2000  Tot. Pop.  0 to 9  10 to 16  17 to 24  25 to 29  30 to 39  40 to 49  50 to 59  60 to 69  70 & over 
Immediate Area  412,674 55,113 38,508 59,586 29,173 60,401 61,097 42,829 28,042 37,925
  Iowa County  15,671 2,198 1,698 1,227 780 2,248 2,508 1,597 1,376 2,039
  Benton  25,308 3,641 2,899 2,098 1,267 4,038 3,850 2,622 1,988 2,905
  Johnson  111,006 12,659 8,406 27,260 10,249 16,065 15,347 9,976 5,079 5,965
  Keokuk  11,400 1,513 1,247 973 561 1,407 1,735 1,168 1,049 1,747
  Linn  191,701 27,430 18,341 22,037 13,491 29,224 29,243 21,086 13,608 17,241
  Poweshiek  18,815 2,212 1,774 2,691 891 2,270 2,707 2,103 1,598 2,569
  Tama  18,103 2,557 1,978 1,538 869 2,328 2,590 1,987 1,669 2,587
  Washington  20,670 2,903 2,165 1,762 1,065 2,821 3,117 2,290 1,675 2,872
Regional Total  1,927,893 259,442 191,014 241,460 124,621 274,260 289,236 211,100 140,989 195,771
State of Iowa  2,926,324 391,016 297,923 342,707 177,259 403,698 439,965 319,183 225,733 328,840
                       
  2010 Proj.  Tot. Pop.  0 to 9  10 to 16  17 to 24  25 to 29  30 to 39  40 to 49  50 to 59  60 to 69  70 & over 
Immediate Area  444,321 60,632 41,436 55,302 28,019 68,219 53,137 56,321 31,169 50,086
  Iowa County  15,104 2,067 1,572 912 661 2,146 2,066 2,290 1,214 2,176
  Benton  26,523 3,995 2,756 1,676 1,178 4,402 3,944 3,605 2,087 2,878
  Johnson  126,778 15,303 9,835 28,275 10,373 18,548 12,772 14,438 6,823 10,410
  Keokuk  10,856 1,390 1,121 834 454 1,435 1,354 1,587 933 1,748
  Linn  208,615 30,449 20,437 18,572 12,818 33,823 26,176 26,590 15,218 24,531
  Poweshiek  18,335 2,200 1,709 2,333 825 2,432 2,035 2,492 1,597 2,712
  Tama  17,659 2,381 1,898 1,269 771 2,432 2,151 2,424 1,560 2,772
  Washington  20,451 2,846 2,108 1,430 939 3,001 2,638 2,896 1,735 2,860
Regional Total  2,006,467 273,228 195,658 213,554 117,016 301,817 241,985 262,357 152,614 248,238
State of Iowa  2,994,094 401,955 297,059 299,930 163,866 439,129 363,213 400,961 235,639 392,343
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Table 7. Population Change from 1990 to 2000 and projected from 2000 to 2010 
  1990-2000  Tot. Pop.  0 to 9  10 to 16  17 to 24  25 to 29  30 to 39  40 to 49  50 to 59  60 to 69  70 & over 
Immediate Area  43,041  3,857  5,096  4,151  (2,927) (277) 16,984  11,393  (98) 4,862 
  Iowa County  1,041  46  300  51  (275) (15) 867  153  (114) 28 
  Benton  2,879  178  454 124  (359) 582  1,231  540  (82) 211 
  Johnson  14,887  695  1,900  2,516  (361) (618) 5,102  4,222  455  976 
  Keokuk  (224) (205) 93  59  (221) (253) 513  15  (198) (27)
  Linn  22,934  3,376  2,206  1,264  (846) 814  7,255  5,374  324  3,167 
  Poweshiek  (218) (326) (85) 39  (306) (510) 534  341  (166) 261 
  Tama  684  124  111  25  (220) (113) 618  202  (138) 75 
  Washington  1,058  (31) 117  73  (339) (164) 864  546  (179) 171 
Regional Total  126,865  487  14,493  12,082  (17,462) (14,279) 69,542  51,994  (9,816) 19,824 
State of Iowa  149,569  (11,525) 18,910  21,668  (29,357) (30,425) 110,712  68,472  (24,074) 25,188 
                       
  2000-2010  Tot. Pop.  0 to 9  10 to 16  17 to 24  25 to 29  30 to 39  40 to 49  50 to 59  60 to 69  70 & over 
Immediate Area  31,647  5,519  2,928  (4,284) (1,154) 7,818  (7,960) 13,492  3,127  12,161 
  Iowa County  (567) (131) (126) (315) (119) (102) (442) 693  (162) 137 
  Benton  1,215  354  (143) (422) (89) 364  94  983  99  (27)
  Johnson  15,772  2,644  1,429  1,015  124  2,483 (2,575) 4,462  1,744  4,445 
  Keokuk  (544) (123) (126) (139) (107) 28  (381) 419  (116) 1 
  Linn  16,914  3,019  2,096  (3,465) (673) 4,599  (3,067) 5,504  1,610  7,290 
  Poweshiek  (480) (12) (65) (358) (66) 162  (672) 389  (1) 143 
  Tama  (444) (176) (80) (269) (98) 104  (439) 437  (109) 185 
  Washington  (219) (57) (57) (332) (126) 180  (479) 606  60  (12)
Regional Total  78,574  13,786  4,644  (27,906) (7,605) 27,557  (47,251) 51,257  11,625  52,467 
State of Iowa  67,770  10,939  (864) (42,777) (13,393) 35,431  (76,752) 81,778  9,906  63,503 
U.S. Census 
Jintanakul, Kanlaya, Dan Otto, and Mark Imerman. Work in progress.  
Iowa State University Department of Economics. 2004. 
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Table 8. U.S. ESRD Incidence and Prevalence 
  By Age (per million population) 
              %Chg
  1980 1985 1990 1995 2000 2001 80-01
Prevalence 
Tot. Pop.  242 445 698 1,044 1,360 1,403 480%
0-19  30 46 58 71 79 80 167%
20-44  220 368 533 721 844 853 288%
45-64  508 914 1,370 1,963 2,457 2,529 398%
65-74  573 1,113 1,931 3,100 4,157 4,318 654%
75+  271 705 1,378 2,345 3,387 3,486 1186%
 
Incidence 
Tot. Pop.  74 122 191 267 332 336 354%
0-19  10 11 14 15 15 16 60%
20-44  53 70 96 123 128 126 138%
45-64  150 241 347 472 525 528 252%
65-74  228 429 727 1,003 1,268 1,292 467%
75+  128 311 596 893 1,340 1,346 952%
Data derived from United States Renal Data System, www.usrds.org 
 
 
Estimate of Growth in Area and Regional Hemodialysis Demand 
 
We have used the data on projected population growth in the local areas and prevalence rate 
trends by age and race for the U.S. to make a rough estimate of the rate of increase in state, area, 
and regional hemodialysis patients from numbers reported in June 2001 to 2010.   
 
 
Table 9. Projected Growth in Area and Regional Dialysis Patient Population 
  From 2001 to 2010 
AREA  PERCENT  2001  PROJECTED 
  GROWTH  PATIENTS  PATIENTS 
       
State of Iowa    75  1946  3414 
Marengo’s Region    75  1322  2318 
Marengo’s Immediate Area  132    219    509 
 
Assuming that no new in-center dialysis chairs (beyond the 5 proposed for Marengo Memorial 
Hospital) are installed, these estimates would generate average patient-per-chair numbers in 2010 
of 5.4 for the entire region and 6.4 for the immediate area.  In the cost information, below, we do 
not consider patient loads of more than 4 per chair.  Under current practice, 6 patients per chair 
would require the facility to be staffed 16 hours per day, six days per week. 
 
We obtained these estimates by  
 
•  extending the known prevalence trend in Iowa out to 2010 
•  applying the latest reported (1999-2001 average) national prevalence shares by age 
and race to the projected Iowa prevalence rate   - 15 -   
•  extending trends in racial (white and nonwhite) shares by age for each of the areas 
and applying them to projected population by age 
•  applying projected prevalence rates by age and race to projected populations by age 
and race for each area 
•  multiplying expected prevalence totals by the most recently observed proportion of 
ESRD patients, nationwide, receiving treatment through in-center hemodialysis  
 
These estimates are for an expected growth in prevalence (total living patients), not for growth in 
incidence, or newly diagnosed ESRD cases.  Increases in total patient numbers reflect both a 
medical problem (increasing numbers of new cases) and a medical success (increasing life 
expectancies for patients in treatment). 
 
It should also be noted that as we move to smaller populations, these estimates would be less 
accurate, as they depend on trends identified at the national level.  These estimates, however, are 
not out of line with the state and national experience from 1990 to 2000.  During the past decade,  
 
•  Iowa ESRD prevalence counts have increased by 92 percent 
•  U.S. ESRD prevalence counts have increased by 115 percent 
•  Iowa ESRD prevalence rates have increased by 76 percent 
•  U.S. ESRD prevalence rates have increased by 95 percent 
•  U.S. dialysis patient counts have increased by 139 percent. 
 
However, even in light of the compatibility of our estimates with the experience of the recent 
past, these estimates depend upon one big “If…” 
 
“If current trends continue…”   
 
The current growth in ESRD incidence is undoubtedly due to a number of factors.  Two factors, 
however, stand out for discussion.  The first of these is lifestyle.  The second is government 
policy. 
 
There is little doubt that some of the increase in ESRD incidence is correlated with lifestyle 
factors related to diet, exercise, hypertension, etc.  Given current societal trends with regard to 
these factors, we should expect ESRD incidence rates to continue rising into the foreseeable 
future.  On the other hand, should society “get religion” on health issues and reform with respect 
to these factors, rates of increase in incidence and actual incident rates could drop. 
 
It is also possible that some of the surge in ESRD incidence rates is related to government policy 
with regard to paying for ESRD treatments.  Certainly, government payment policies affect the 
proportions of ESRD patients that are treated by in-center hemodialysis.  The extension, in 1972, 
of federal Medicare coverage to all ESRD patients requiring dialysis or transplantation, regardless 
of age, undoubtedly provided incentives for earlier diagnoses of renal disease cases to ensure 
treatment of other conditions in otherwise noncovered populations.  Federal policies that favor in-
center dialysis over home dialysis also affect the distribution of treatment modalities.  To the 
extent that federal policies have elicited a “surge” in incidence and in-center dialysis treatments, 
one might expect an eventual leveling off of this effect, slowing the increase in incidence rates.  
Changes in federal policies favoring in-center hemodialysis could cause a fall in the demand for 
in-center treatment even in an environment of increasing prevalence.  
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Finally, regardless of any “Ifs,” kidney failure, in the absence of any complicating factors, is age 
related.  As we continue to enjoy increasing life expectancies, and we continue to extend the lives 
of patients suffering from kidney-related or totally unrelated diseases, we will expect higher 
incident levels of kidney failure.  We will also see increasing life expectancies among patients 
suffering from kidney failure.  For these reasons, the questions regarding the big “If,” above, are 
questions of scale.  Absent a major breakthrough in prevention and cure, we will see increasing 
numbers of patients needing some form of kidney-function support.  The questions relate only to 
how fast these numbers will grow and how these cases are treated. 
 
 
Costs and Revenues 
 
The cost analysis portion of this analysis will focus only on the direct costs that are specifically 
required in order to establish and operate the proposed dialysis center.  It is assumed that suitable 
space for a 5-station hemodialysis center will be made available in the planned addition to the 
Marengo Memorial Hospital.  It is also assumed that there are sufficient staff support, supply, and 
business office capabilities existing within the hospital organization and infrastructure to support 
or absorb the needs of the proposed dialysis center.   
 
As a result, the cost analysis done here will not address facility construction or amortization costs, 
general business office costs, general supply organization and storage costs, or general staff 
support costs.  These cost items are generally referred to as “Overhead.”  We are assuming that 
current overhead investments and expenses at Marengo Memorial Hospital are not fully exploited 
and, at least in the initial stages of dialysis-center operations, can be spread across the support of 
these additional services.  Savings to the overall hospital budget would offset any overhead costs 
allocated to the dialysis facility.  This becomes an accounting formality that is ignored, here, for 
the sake of simplicity. 
 
In general, in-center hemodialysis patients receive treatments three times per week.  Treatments 
last about 4 hours and require about an hour total for set-up and clean-up time, resulting in a per-
treatment cycle of approximately 5 hours.  Treating two patients per chair requires three ten-hour 
days per week (two patients times five hours times three treatments per week).  Moving from two 
to three patients per chair requires either moving to three 15-hour days per week, or maintaining 
three 10-hour days and adding three five-hour days.  Four patients per chair can be done with six 
10-hour days.  There is some facility maintenance that has to be performed outside of the 
treatment cycle.  Regardless of the number of cycles run in a day, it is assumed that staff will be 
required at the facility for one additional hour to perform basic maintenance and preparations. 
 
Because the required operating staff support for a five-chair dialysis facility is relatively constant 
whether one chair or five chairs are in use, the goal is to operate on a schedule that keeps all five 
chairs full or the entire facility shut down.  As a result, optimal patient loads would come at levels 
of five patients (one per chair), ten patients (two per chair), 15 patients, or 20 patients.  
Obviously, fixed costs per patient decline as the number of patients increases.  Operating labor 
costs remain relatively constant per patient as long as the facility is full when it operates.  
Administrative labor costs per patient decline as more patients are added. 
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Table 10. Definition of shift cycles 
A.1-2  One cycle with one or two patients 
A.3-5  One cycle with between three and five patients 
B.6-7  Two cycles; one cycle full and one cycle with one or two patients 
B.8-10  Two cycles; one cycle full and one cycle with between three and five patients 
C.11-12  Three cycles; two cycles full and one cycle with one or two patients 
C.13-15  Three cycles; two cycles full and one cycle with between three and five patients 
D.16-17  Four cycles; three full cycles and one cycle with one or two patients 
D.18-20  Four cycles; three full cycles and one cycle with between three and five patients 
 
Cycles for any number of shifts, defined in Table 10, are split according to the utilization level of 
the last cycle added.  It is assumed that a cycle with less than three patients can be operated with 
only a registered nurse and a chief technician.  For cycles serving three or more patients, a patient 
care technician is added.  As mentioned earlier, from an efficiency standpoint, it is optimal to 
operate fully-populated cycles.  Direct staffing needs, hourly wages, and annual wages and 
benefits for each of the possible shift cycles are shown in Table 11.  Wage rates were taken from 
statewide workforce statistics.  Shift costs divided by patients served are included in the estimated 
annual costs per patient that drive Graph 3. 
 
 
Table 11.  Directly-employed staff requirements for dialysis center operating 
schedules 
    A.1-2 A.3-5 B.6-7 B.8-10 C.11-12 C.13-15 D.16-17 D.18-20
HOURS/WEEK                   
Registered nurse    25 25 40 40 58 58 73 73
Patient care technician      18 18 33 33 51 51 66
Chief technician    18 18 33 33 51 51 66 66
                   
SALARY COST  $/Hour               
Registered nurse  18.6 24,264 24,264 38,822 38,822 56,292 56,292 70,850 70,850
Patient care technician  13.36 0 12,548 12,548 23,005 23,005 35,553 35,553 46,010
Chief technician  15.43 14,492 14,492 26,570 26,570 41,062 41,062 53,139 53,139
                   
Benefits (30% X salary)   11,627 15,391 23,382 26,519 36,108 39,872 47,863 51,000
                   
TOTAL COST    50,383 66,696 101,322 114,916 156,467 172,779 207,405 220,999
 




Renal Social Worker 
Hemodialysis Dietician  
 
These three positions can be covered on a partial-time contract or retainer basis.  Unlike the labor 
costs in Table 11, these costs are not shift-dependent.  Once contracted, these costs are fixed 
costs.  Ranges for these costs are included in Table 13, below.  The actual negotiated value of 
these contracts will depend upon the ability to fit these duties into a workable annual employment 
options for either the hospital or the employee.  The dietician contract might be attached to other 
dietician work at the hospital.  The social work position might be shareable within the hospital or 
with other less-than-full-time social work positions in the local area.  The medical director   - 18 -   
contract might be a method of augmenting the incentives for a local doctor to remain in the area, 
or it might be shared with other dialysis facilities in the area or region. 
 
Table 12 provides estimates of completely variable costs.  These are costs that should depend 
directly upon the number of treatments that the facility provides or the number of patients that are 
regularly served.  Table 12 contains a separate subtotal for equipment maintenance and dialysis 
supplies, as these are direct costs of the dialysis process and will be billed as dialysis services.  
Medication costs are generally considered and reported as an addition to dialysis costs.       
 
 
Table 12. Variable Dialysis and Medication Costs 
Dialysis equip. maintenance  880
Biomedical dialysis supplies   
Dialysis supplies: dialysate, dialyzers,   
chemicals, supplies, disposable linens, etc.  5,874
Biomedical material disposal  463
Dialysis Total  7,217
   
Patient medications   
Medications: EPO, Vitamin D, etc.  9,839
   
Total Dialysis and Medication  17,056
Modified from Lawler, Mary K., et al.,  
“A Systems Development Guide for a Kidney Dialysis Center” 
 Oklahoma State University 
 
Table 13 provides a list of equipment, supplies, and contract staff that are needed to open a 
facility, regardless of the facility’s utilization rate.  These are establishment costs.  They do not 
depend upon the number of cycles or the number of patients.  They depend upon the size of the 
facility established.  Low, high, and mid prices are included for most of the items in Table 13.  
For the categories of “Facility infrastructure,” “Dialysis station equip.,” and “Patient-care equip. 
pool,” three prices were generally obtained.  Staff at Marengo Memorial Hospital provided two of 
these.  The third was included in “A Systems Development Guide for a Kidney Dialysis Center,” 
a 2003 publication of the Oklahoma State University Dept. of Agricultural Economics.  Low and 
high prices were identified from this set.  Mid price is the midpoint between the low and high 
price (not the average of the three prices).  For two of the remaining categories (“Water 
treatment” and “Biomedical equipment”) only Oklahoma State University estimates were used.  
For the final category, “Fixed staff costs,” ranges were developed around point estimates 
provided by Oklahoma State University. 
 
For each of the categories, unit costs are multiplied by number of units to provide a range of total 
establishment costs.  In the final series of columns, establishment costs for all categories except 
“Fixed staff costs,” which are annual, are divided by an average life expectancy of seven years to 
provide an estimate of annualized establishment costs.  These costs are then divided by numbers 
of possible patients ( 1 through 20) to provide input into the estimated annual costs per patient 
that drive Graph 3.   
 
It should be noted that annual costs are calculated by simple division.  They are not amortized 
with respect to an assumed interest rate.  All cost and revenue estimates within this report assume 
that the value of money remains constant throughout the period of analysis (inflation is zero).    - 19 -   
This allows users to easily make independent assumptions about rates of change in revenue 
values and individual costs.   
 
Graph 3 provides a visual perspective of expected costs per patient for the facility.  These costs 
assume that patients are regular recipients of dialysis in the proposed facility and that the facility 
consistently operates at one of the shift levels defined in Table 10.  Graph 3 provides two sets of 
Low, High, and Mid trend lines.  One includes Medications from Table 12, and one does not.  
Medications will be provided in the course of dialysis, in any event.  Separating them out in 
Graph 3 assists interpreting the trend if medications are provided from outside the hospital or if 
they are billed under a separate system.  Table 14 provides the cost per patient numbers for 
utilization levels above 3 patients. 
 
Revenue estimates begin with Table 15.  This table shows annual average Medicare payouts per 
patient for outpatient hemodialysis treatments at a state and national level.  The table includes 
only payments to outpatient hemodialysis facilities for functions and medications directly related 
to the hemodialysis service.  There area additional physician and hospital services (minor 
surgeries, laboratory work, emergency treatment, ambulance, etc.) that Medicare will pay for, but 
are not directly attached to the dialysis process.   
 
Table 15 shows annual payouts per patient year at risk.  This assumes that a patient comes in for 
regular dialysis three times a week and fifty-two weeks a year.  The average hemodialysis patient 
spends approximately 14 days per year admitted to a hospital.  During this time, Medicare does 
not make treatment payments to the outpatient hemodialysis facility (though it does make 
payments to the hospital for inpatient care).  As a result, these payments should be discounted by 
about 4 percent to arrive at actual payments per patient.   
 
Table 15 also assumes that the patient is beyond the 90 day waiting period prior to eligibility for 
Medicare.  If we assume a 5-year life expectancy from the initiation of treatment and that 
waiting-period treatment billings are written off, then the Table 15 payments should be 
discounted by an additional 5 percent (a lower assumed life-expectancy would result in a greater 
discount).  Combining these discounts would result in annual average Medicare payments of 
approximately $19,918 per patient for the U.S. as a whole and $22,940 per patient for Iowa.  
These numbers include medications and should be compared with the average total costs per 
patient lines in Table 14 and Graph 3. 
 
Nonmedicare patients are billed at a significantly higher rate than are Medicare patients.  Urban 
hospitals within the region experience nonmedicare patient rates of up to 25%, and bill these 
patients at up to 5 times the Medicare billing rate (actual insurance and private payments vary 
significantly from billed rates).  Assuming a private-payer yield of 2.5 times the rate of  Medicare 
payments per patient would result in nonmedicare revenue of $57,350 per patient, annually.  If it 
was also assumed that nonmedicare patients are not discounted for the 90-day waiting period, 
their estimated yield per-patient would move up to $59,872, annually. 
 
Clearly, the addition of nonmedicare patients has a substantial effect on expected revenue per 
hemodialysis patient.  Given the revenue assumptions discussed above, a 10-percent rate of 
nonmedicare patients would increase the expected yield per patient for the operation from 
$22,940 to $26,633, annually.   
 
It is unclear, however, what the rate of nonmedicare patients would be for a proposed 
hemodialysis facility in Marengo.  Rural areas tend to have much lower proportions of 
nonmedicare patients.  It is not unusual for rural facilities in the region to depend 100 percent   - 20 -   
upon Medicare patients.  Marengo’s location just west of an urban growth region may increase its 
probability of obtaining nonmedicare patients beyond that of a purely rural location. 
 
Finally, all of the discussions regarding costs and revenues in this report are preliminary.  While it 
is not certain, from these estimates, that a 5-station dialysis facility at Marengo Memorial 
Hospital would cash-flow, it is not beyond the very reasonable possibility that it could do so.  The 
numbers here, derived largely from national averages and academic studies, provide an indication 
that in-depth exploration of this facility could be worthwhile.  It is certain that the cost scenarios 
that can be obtained by an potential buyer in an active market will be different from those 
available to speculative academics. 
 
 
Speculation on Industry Trends 
 
The hemodialysis industry seems destined to decentralize, geographically, for a couple of 
reasons.  First, there is continued dramatic growth in patient numbers in both rural and urban 
areas.  Increasing patients make it possible to generate financially-critical patient numbers in rural 
areas.  Second, dialysis equipment and facilities continue to become smaller and more cost-
effective.  This means that financially-critical patient numbers necessary to support facilities 
should continue to fall even as the number of available patients continues to rise.  The 
combination of these factors, by themselves, should lead to increasing numbers of rural dialysis 
facilities. 
 
Changing regulation may also add to the decentralization trend in dialysis.  Dialysis treatments 
are tightly bound by Medicare participation rules.  The four-hour per treatment, three-treatment 
per week regimen is mandated by Medicare reimbursement.  Growing bodies of evidence indicate 
that treatment could be more effective in terms of both cost and patient welfare on a two-hour per 
treatment, six-treatment per week cycle.  Dialysis is clearly more efficient for the first two hours 
of the process, and patients treated every day do not experience the extreme internal chemistry 
fluctuations that result from every-other-day treatment.  Daily treatment would increase the 
number of visits required and provide an incentive for patients to further minimize distance 
traveled.  Should Medicare change to reimburse treatment beyond three per patient per week, this 
will provide a further incentive to geographically disperse dialysis facilities. 
 
Geographic dispersion of dialysis facilities, however, does not equate to decentralization of 
ownership, management, or control.  It is quite likely that management of dialysis facilities will 
become more centralized as facilities become more decentralized.  This is due to both labor and 
secondary treatment considerations.  
 
Small dialysis facilities, whether free-standing or hospital based, will increasingly have a harder 
time maintaining sufficient staff on a continuous basis.  This is partially because small facilities 
do not provide the number of patients required to fully employ some highly specialized staff.  As 
facilities decentralize, more of these staff will be shared, and staff sharing lends itself to joint 
management.  In addition, small facilities have trouble maintaining continuity in full-time staff.  
Nurses and technicians are highly mobile in the job market.  Maintaining operating staff in the 
face of mobility requires some level of redundancy, and smaller facilities face difficulties in 
maintaining this redundancy.  Jointly managed facilities will continue to find it easier to maintain 
the redundancy or staff sharing arrangements that make continued operations on a small scale 
workable. 
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Table 13. Establishment costs 
 No.                Total Cost     Life:     Annual Cost   
    Low  High  Mid    Low  High  Mid   yrs.  Low  High  Mid 
                 
Facility infrastructure                 
Lab refrigerator  1  150  6316  3233   150 6,316  3,233   7  21 902  462
Lab freezer  1  275  4,743  2,509   275 4,743  2,509   7  39 678  358
Meds refrigerator  1  150  1,200  675   150 1,200  675   7  21 171  96
EPO refrigerator  1  150  1,934  1,042   150 1,934  1,042   7  21 276  149
Ice machine  1  400  3,000  1,700   400 3,000  1,700   7  57 429  243
Chart rack  1  55  700  378   55 700  378   7  8 100  54
Computer system  1  1,500  5,000  3,250   1,500 5,000  3,250   7  214 714  464
Shelving  1  315  630  473   315 630  473   7  45 90  68
   Facility infrastructure          2,995 23,523  13,259     428 3,360  1,894
                 
Water treatment                 
R/O system (cap. up to 30 tx/day)  1  25,000  25,000  25,000   25,000 25,000  25,000   7  3,571 3,571  3,571
Drum dolly  1  300  300  300   300 300  300   7  43 43  43
Central bi-carb system  1  2,000  2,000  2,000   2,000 2,000  2,000   7  286 286  286
   Water treatment          27,300 27,300  27,300     3,900 3,900  3,900
                 
Biomedical equipment                 
Electrical analyzer/tester  1  2,195  2,195  2,195   2,195 2,195  2,195   7  314 314  314
Conductivity meter  1  233  233  233   233 233  233   7  33 33  33
dialysate meter  1  275  275  275   275 275  275   7  39 39  39
R/O tds water meter  1  61  61  61   61 61  61   7  9 9  9
Water analysis test kit  1  25  25  25   25 25  25   7  4 4  4
Heat block  1  462  462  462   462 462  462   7  66 66  66
portable tool chest and tools  1  30  30  30   30 30  30   7  4 4  4
Parts storage cart  1  238  268  253   238 268  253   7  34 38  36
Misc. tools, fittings, & tubing  1  3,000  3,000  3,000   3,000 3,000  3,000   7  429 429  429
Hardness test kit  1  30  30  30   30 30  30   7  4 4  4
   Biomedical equipment          6,549 6,579  6,564     936 940  938
Continued on next page 
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Table 13. Establishment costs (cont’d.) 
 No.                Total Cost     Life:     Annual Cost   
    Low  High  Mid    Low  High  Mid   yrs.  Low  High  Mid 
                 
Dialysis station equip.                 
Dialysis machines  6  15,000  16,550  15,775   90,000 99,300  94,650   7  12,857 14,186  13,521
Dialysis chair  5  750  1,720  1,235   3,750 8,600  6,175   7  536 1,229  882
Privacy screen  5  148  200  174   740 1,000  870   7  106 143  124
Task stool  5  50  265  158   250 1,325  788   7  36 189  113
Stethoscope  3  10  50  30   30 150  90   7  4 21  13
Trash can  5  35  155  95   175 775  475   7  25 111  68
Infectious waste hampers  5  45  100  73   225 500  363   7  32 71  52
Television  5  200  1,001  601   1,000 5,005  3,003   7  143 715  429
   Dialysis station equip.          96,170 116,655  106,413     13,739 16,665  15,202
                 
Patient-care equip. pool                 
Patient lift  1  800  4,000  2,400   800 4,000  2,400   7  114 571  343
Wheelchair  1  199  450  325   199 450  325   7  28 64  46
Wheelchair/standup scales  1  1,971  2,500  2,236   1,971 2,500  2,236   7  282 357  319
Subacute bed  1  1,592  1,592  1,592   1,592 1,592  1,592   7  227 227  227
Mobile blood-pressure modules  3  111  200  156   333 600  467   7  48 86  67
Ambu bag  1  18  250  134   18 250  134   7  3 36  19
Oxygen equipment  2  150  693  422   300 1,386  843   7  43 198  120
Infusion pump  2  950  2,500  1,725   1,900 5,000  3,450   7  271 714  493
IV pole  2  85  125  105   170 250  210   7  24 36  30
Glucometer  1  45  88  67   45 88  67   7  6 13  10
Thermometer  2  150  250  200   300 500  400   7  43 71  57
Ultrasonic mini doppler  1  500  712  606   500 712  606   7  71 102  87
Emergency evacuation kit  2  100  150  125   200 300  250   7  29 43  36
Miscellaneous clinical  1  50  1,000  525   50 1,000  525   7  7 143  75
Bed pan  3  3  75  39   9 225  117   7  1 32  17
Crash cart  1  1,219  1,219  1,219   1,219 1,219  1,219   7  174 174  174
   Patient-care equip. pool          9,606 20,072  14,839     1,372 2,867  2,120
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Table 13. Establishment costs (cont’d.) 
 No.                Total Cost     Life:     Annual Cost   
    Low  High  Mid    Low  High  Mid   yrs.  Low  High  Mid 
                 
Fixed staff costs                 
Medical director/nephrologist  1  30,000  50,000  40,000   30,000 50,000  40,000   1  30,000 50,000  40,000
Renal social worker  1  5,000  10,000  7,500   5,000 10,000  7,500   1  5,000 10,000  7,500
Hemodialys dietician  1  5,000  10,000  7,500   5,000 10,000  7,500   1  5,000 10,000  7,500
Pagers for staff  1  2,400  4,800  3,600   2,400 4,800  3,600   1  2,400 4,800  3,600
Staff development  1  4,000  8,000  6,000   4,000 8,000  6,000   1  4,000 8,000  6,000
   Fixed staff cost          46,400 82,800  64,600     46,400 82,800  64,600
                 
TOTALS          189,020 276,929  232,975     66,774 110,533  88,654
 
 
Table 14.  Estimated Costs Per Patient Per Year 
  4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Total Cost Est.                                 
Low Estimate  50,423 43,750 45,072 41,070 39,767 37,244 35,225 37,351 35,659 35,483 34,167 33,026 34,192 33,184 33,043 32,202 31,445
High Estimate  61,363 52,502 52,365 47,321 45,237 42,106 39,601 41,329 39,306 38,849 37,292 35,943 36,927 35,758 35,474 34,505 33,633
Mid Range  55,893 48,126 48,718 44,195 42,502 39,675 37,413 39,340 37,483 37,166 35,730 34,485 35,560 34,471 34,259 33,353 32,539
                                   
With No Medication Costs                               
Low Estimate  40,584 33,911 35,233 31,231 29,928 27,405 25,386 27,512 25,820 25,644 24,328 23,187 24,353 23,345 23,204 22,363 21,606
High Estimate  51,524 42,663 42,526 37,482 35,398 32,267 29,762 31,490 29,467 29,010 27,453 26,104 27,088 25,919 25,635 24,666 23,794
Mid Range  46,054 38,287 38,879 34,356 32,663 29,836 27,574 29,501 27,644 27,327 25,891 24,646 25,721 24,632 24,420 23,514 22,700
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Table 15.  Medicare Payments Per Patient Year At Risk 
  Outpatient Hemodialysis (1997-2001 average) 
  U.S.  IOWA
   
Patient years at risk   861,423  1,355
   
Total outpatient   21,887  25,209
     Outpatient hemodialysis   12,485  13,968
     Outpatient EPO   4,941  5,259
     Outpatient vitamin D hormones   1,029  2,068
     Outpatient iron   760  700
     Outpatient other injectables   284  547
     Radiology   352  415
     Pharmacy   350  261
     Laboratory/pathology   355  480
     Outpatient other   1,331  1,511
United States Renal Dialysis Data System 
http://www.usrds.org/odr/xrender_home.asp. 
 
Secondary treatment and emergency services are also an issue that leads towards joint 
management of small facilities.  Hemodialysis facilities must maintain agreements with hospitals 
that are capable of taking care of emergency situations related to dialysis patients.  In addition to 
emergency referral, there are complications in end-stage renal disease that many small facilities 
will be unable to effectively treat.  For both of these reasons, affiliation with larger centralized  
hospitals will be inevitable for smaller rural dialysis facilities.  These affiliations will often extend 
to staff management or staff sharing agreements either with the central hospital or among a group 





This study was commissioned to look at the potential market for additional hemodialysis facilities 
in the Marengo area and to do a preliminary analysis of financial issues in the development of a 
five-station facility in Marengo.   There are two basic conclusions to this work. 
 
First, there is almost certainly going to be growth in demand for hemodialysis services in the 
Marengo area that outstrips current supply facilities.  This is due to both expected increases in 
area populations and expected increases in ESRD prevalence within area populations.  While 
Marengo’s home county is not expected to grow over the next several years, a high proportion of 
area population growth is expected to occur in western Johnson and Linn Counties, directly 
between Marengo and the closest alternative dialysis facilities. 
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Second, cost and revenue estimates used in this study do not guarantee that a Marengo facility 
will cash-flow.  This is not an indication that consideration of the facility should cease, but it does 
warrant 
 
•  More analysis of the interaction between the potential dialysis facility and the existing 
hospital 
•  A more locally-focused analysis of required equipment and minimum costs 
•  Exploration of more management and staffing/compensation options. 
 
The existence of viable well-managed hemodialysis centers in the current demand environment 
should be an indication that additional well-managed hemodialysis facilities will be successful in 
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The staff at Marengo Memorial Hospital. 
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